KQ · Healthcare

Hyundai Bioscience Co. Ltd (048410)

Biotechnology

Hyundai Bioscience Co. Ltd (048410) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 048410

P/E ratio

25.00

Hyundai Bioscience Co. Ltd (048410) — FAQ

What is 048410's P/E ratio?

The price-to-earnings (P/E) ratio for Hyundai Bioscience Co. Ltd (048410) is 25.00 (data as of 2026-05-24).

Does Hyundai Bioscience Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Hyundai Bioscience Co. Ltd (048410). Check the MyAverix Finance app for the latest dividend data.

What sector is Hyundai Bioscience Co. Ltd in?

Hyundai Bioscience Co. Ltd (048410) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 048410 listed on?

048410 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)